Rating History for Enliven Therapeutics (ELVN) by Stifel

More Stocks Rated by Stifel | Latest Ratings for ELVN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/1/2026 Dara Azar Maintain Buy
(N/A)		 80.00
(60.00)		  
 		   Details